Although Clostridium perfringens Type B is not considered a
significant problem in the U.S.A., immunity may be provided against the beta
and epsilon toxins elaborated by Cl. perfringens Type B. The
immunity is derived from the combination of Type C (beta) and Type D (epsilon)
fractions.

Dosage For further information including dose rate and complete directions and
warnings, please see the Product Label.